The FDA isn't likely to let companies skip animal tests altogether, but the chip should identify likely losers earlier in the process, knocking up to $100 million off the cost of drug approval.
尽管美国食品药物管理局不太可能允许制药公司完全省略动物测试，芯片装置应该可以及早甄别可能失败的实验药品，从而避免最高可达1亿美元的药品审批费用。
The FDA isn't likely to let companies skip animal tests altogether, but the chip should identify likely losers earlier in the process, knocking up to $100 million off the cost of drug approval.
尽管美国食品药物管理局不太可能允许制药公司完全省略动物测试，芯片装置应该可以及早甄别可能失败的实验药品，从而避免最高可达1亿美元的药品审批费用。
应用推荐